中国医师进修杂志
中國醫師進脩雜誌
중국의사진수잡지
CHINESE JOURNAL OF POSTGRADUATES OF MEDICINE
2014年
33期
47-49
,共3页
成人%变应性鼻-鼻窦炎%亚急性咳嗽%丙酸氟替卡松%西替利嗪
成人%變應性鼻-鼻竇炎%亞急性咳嗽%丙痠氟替卡鬆%西替利嗪
성인%변응성비-비두염%아급성해수%병산불체잡송%서체리진
Adult%Allergic rhinitis-sinusitis%Subacute cough%Fluticasone propionate%Cetirizine
目的 探讨丙酸氟替卡松鼻喷雾剂联合西替利嗪治疗变应性鼻-鼻窦炎致成年人亚急性咳嗽临床疗效.方法 筛选由变应性鼻-鼻窦炎致亚急性咳嗽56例成年人患者,按随机数字表法分为治疗组与对照组,每组28例.对照组给予一般止咳化痰药复方甘草合剂,治疗组在此基础上给予丙酸氟替卡松鼻喷雾剂联合西替利嗪片,观察并记录用药前后咳嗽轻重程度及不良反应.结果 治疗组的总有效率为82.1%(23/28),而对照组总有效率为53.6%(15/28),治疗组疗效明显优于对照组,差异有统计学意义(P<0.01).结论 丙酸氟替卡松鼻喷雾剂联合西替利嗪治疗变应性鼻-鼻窦炎致成年人亚急性咳嗽效果良好,值得临床推广.
目的 探討丙痠氟替卡鬆鼻噴霧劑聯閤西替利嗪治療變應性鼻-鼻竇炎緻成年人亞急性咳嗽臨床療效.方法 篩選由變應性鼻-鼻竇炎緻亞急性咳嗽56例成年人患者,按隨機數字錶法分為治療組與對照組,每組28例.對照組給予一般止咳化痰藥複方甘草閤劑,治療組在此基礎上給予丙痠氟替卡鬆鼻噴霧劑聯閤西替利嗪片,觀察併記錄用藥前後咳嗽輕重程度及不良反應.結果 治療組的總有效率為82.1%(23/28),而對照組總有效率為53.6%(15/28),治療組療效明顯優于對照組,差異有統計學意義(P<0.01).結論 丙痠氟替卡鬆鼻噴霧劑聯閤西替利嗪治療變應性鼻-鼻竇炎緻成年人亞急性咳嗽效果良好,值得臨床推廣.
목적 탐토병산불체잡송비분무제연합서체리진치료변응성비-비두염치성년인아급성해수림상료효.방법 사선유변응성비-비두염치아급성해수56례성년인환자,안수궤수자표법분위치료조여대조조,매조28례.대조조급여일반지해화담약복방감초합제,치료조재차기출상급여병산불체잡송비분무제연합서체리진편,관찰병기록용약전후해수경중정도급불량반응.결과 치료조적총유효솔위82.1%(23/28),이대조조총유효솔위53.6%(15/28),치료조료효명현우우대조조,차이유통계학의의(P<0.01).결론 병산불체잡송비분무제연합서체리진치료변응성비-비두염치성년인아급성해수효과량호,치득림상추엄.
Objective To research the therapeutic effect of fluticasone propionate nasal combined with cetirizine in the treatment of allergic rhinitis-sinusitis caused adult subacute cough.Methods Allergic rhinitis-sinusitis caused adult subacute cough of 56 patients were randomly divided into study group and control group with 28 cases each group by random digits table method.They were treated with cough expectorant drugs commonly brown mixture,the study group was additionally given fluticasone propionate nasal combined with cetirizine.The therapeutic effect and adverse reactions were compared.Results The total effective rate of study group was 82.1% (23/28),which was superior to control group 53.6% (15/28),there which was statistical difference (P < 0.01).Conclusion Fluticasone propionate nasal combined with cetirizine in treatment of allergic rhinitis-sinusitis caused adult subacute cough effect is good,and is worthy of clinical promotion.